USA flag logo/image

An Official Website of the United States Government

OPPORTUNISTIC INFECTION IMAGING IN AIDS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
18937
Program Year/Program:
1992 / SBIR
Agency Tracking Number:
18937
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Rhomed, Inc.
C/O PALATIN TECHNOLOGIES, INC. Princeton, NJ 08540
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1992
Title: OPPORTUNISTIC INFECTION IMAGING IN AIDS
Agency: HHS
Contract: N/A
Award Amount: $46,211.00
 

Abstract:

OPPORTUNISTIC INFECTIONS ARE A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN AIDS PATIENTS. ALTHOUGH IT IS GENERALLY BELIEVED THAT THE EARLY DIAGNOSIS AND TREATMENT OF AN OPPORTUNISTIC INFECTION IS CRITICAL TO DECREASING MORBIDITY AND INCREASING OVERALL SURVIVAL, LOCALIZING THE SITE OF THESE INFECTIONS IS OFTEN DIFFICULT. CURRENTLY, THERE ARE TWO ACCEPTED TECHNIQUES FOR WHOLE-BODY EVALUATION USING RADIONUCLIDES: 111IN-OXINE-LABELED AUTOLOGOUS WHITE BLOOD CELL (WBC) SCINTIGRAPHY AND 67GA CITRATE SCINTIGRAPHY. THE OBJECTIVE OF THIS PROJECT IS TO TEST THE USE OF A 99MTC-LABELED, MONOCLONAL ANTIBODY-BASED IMAGING REAGENT FOR DETECTING HIDDEN INFECTIONS IN PATIENTS WITH AIDS. THE ANTIBODY BINDS TO THE SURFACES OF HUMAN NEUTROPHILS, THUS PERMITTING IN VIVO TAGGING OF THE CELLS MOST LIKELY TO BE FOUND AT THE SITE OF AN ABSCESS OR INFECTION. WE EXPECT THAT THE USE OF THE 99MTC-LABELED ANTIBODY WILL IMPROVE THE TIMELINESSAND ACCURACY OF DIAGNOSIS, AND WILL ELIMINATE THE RISKS ASSOCIATED WITH THE USE OF EX VIVO- LABELED, 111IN WHITE BLOOD CELLS.

Principal Investigator:

Teresa A Coons
5053447200

Business Contact:

Small Business Information at Submission:

Rhomed Inc
1020 Tijeras Ne Albuquerque, NM 87106

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No